Zobrazeno 1 - 10
of 36
pro vyhledávání: '"R Gavira-Moreno"'
Autor:
MDP Briceño Casado, MD Gil-Sierra, CM Cuadros-Martinez, B De La Calle-Riaguas, R Gavira-Moreno
Publikováno v:
Late breaking abstracts.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::6c2e413dca323bae0d660ecb25081d78
https://doi.org/10.1136/ejhpharm-2023-eahp.386
https://doi.org/10.1136/ejhpharm-2023-eahp.386
Publikováno v:
Section 5: Patient Safety and Quality assurance.
Background and importance Palbociclib and ribociclib are equivalents in terms of effectiveness in the treatment of metastatic breast cancer (mBC) HER2 negative with positive hormone receptors (RH). The randomised studies PALOMA-2/3 and MONALEESA-2/3
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::7a3ec2d01ea9629a80eb4f8873b28675
https://doi.org/10.1136/ejhpharm-2020-eahpconf.435
https://doi.org/10.1136/ejhpharm-2020-eahpconf.435
Autor:
JF Sierra Sánchez, R Gavira Moreno, P Gómez Germá, A Varas Pérez, V Vazquez Vela, C Puivecino Moreno
Publikováno v:
Section 4: Clinical Pharmacy Services.
Background and importance Drug management of haematological patients is complex because it integrates numerous agents (antineoplastics, supportive care and medications for comorbidities). In the ambulatory setting, the clinical pharmacist can contrib
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::1656a090f93d4a505e4a68e23a53e546
https://doi.org/10.1136/ejhpharm-2020-eahpconf.197
https://doi.org/10.1136/ejhpharm-2020-eahpconf.197
Autor:
R Gavira Moreno, A Varas Pérez, JF Sierra Sánchez, L Jiménez Pichardo, R Gázquez Pérez, A Alcala Soto, MT Gómez de Travecedo y Calvo, V Sanchez-Matamoros Piazza, C Puivecino Moreno, V Vazquez Vela
Publikováno v:
Section 5: Patient Safety and Quality Assurance.
Background In long-term safety studies of sunitinib, most adverse events (AE) occurred initially between the first 6 months and 1 year, and remained stable or decreased in frequency over time. Purpose To analyse the safety and tolerability of sunitin
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::9c25231f56d6a73d152df3ba61263132
https://doi.org/10.1136/ejhpharm-2019-eahpconf.478
https://doi.org/10.1136/ejhpharm-2019-eahpconf.478
Autor:
A Varas-Perez, R Gavira-Moreno, V Sanchez-Piazza, JF Sierra-Sanchez, C Puivecino Moreno, R Gazquez-Perez, A Alcala Soto
Publikováno v:
Section 2: Selection, Procurement and Distribution.
Background A Therapeutic Positioning Report published by the Spanish Agency for Medicines and Healthcare Products concludes that there are no differences in efficacy and safety between nivolumab, pembrolizumab and atezolizumab for patients with lung
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::a72c1823769c7fd717ef02a2e6fb690a
https://doi.org/10.1136/ejhpharm-2019-eahpconf.47
https://doi.org/10.1136/ejhpharm-2019-eahpconf.47
Autor:
M.J. Castro Dorantes, S.J. Jiménez Delgado, P. Alamillos Ortega, P. Beardo Villar, R Gavira Moreno, A.B. Pérez Pérez
Publikováno v:
Revista de Calidad Asistencial. 31:234-238
Resumen Objetivo Determinar la efectividad de un programa de tratamiento con quimioterapia precoz para pacientes con cancer vesical no musculo infiltrante antes y despues de un plan de formacion y comunicacion dirigido a los profesionales que intervi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::b73ce83086cd4fb2cdfd9b8c51555787
https://doi.org/10.1016/j.cali.2015.10.004
https://doi.org/10.1016/j.cali.2015.10.004
Autor:
JF Sierra Sánchez, A Alcala Soto, A Varas Pérez, L Jiménez Pichardo, MT Gómez de Travecedo y Calvo, C Puivecino Moreno, R Gavira Moreno
Publikováno v:
Eur J Hosp Pharm
BACKGROUND: There is only limited information about the sequential use of abiraterone acetate (AA) and enzalutamide (ENZ) in metastatic castration-resistant prostate cancer (mCRPC) patients. Patients who receive AA or ENZ as first-line therapy and su
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::98c7c94999e4dc5ff52494f1b14ac9e6
https://europepmc.org/articles/PMC7535372/
https://europepmc.org/articles/PMC7535372/
Publikováno v:
Eur J Hosp Pharm
BackgroundImproving the quality of drug prescriptions is part of the corporate objectives of health systems. Finding the correlation between the quality of the prescription measured through a synthetic quality indicator (SIQ) and the prevalence of po
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::cf835d743769d2ea1633441aa9037a1e
https://doi.org/10.1136/ejhpharm-2018-eahpconf.463
https://doi.org/10.1136/ejhpharm-2018-eahpconf.463
Autor:
C Mora Herrera, MT Góme de Travecedo y Calvo, A Alcala Soto, MA Almendral Vicente, JF Sierra Sánchez, R Gavira Moreno, L Jiménez Pichardo, C Puivecino Moreno, E Atienza Gil, P Gómez Germá
Publikováno v:
Clinical pharmacy.
Background Although clinical trials show low virological failures rates ( Purpose To evaluate the switch rate among naive patients who begin ART and to determine the reasons that led to a change in the ART regimen. Material and methods We conducted a
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::6f7b1745ac658796270d384cfc8c0b4c
https://doi.org/10.1136/ejhpharm-2017-000640.231
https://doi.org/10.1136/ejhpharm-2017-000640.231
Autor:
J. Soto-Villalba, J.L. Alvarez-Ossorio, Alvaro Juarez-Soto, M.J. Ledo-Cepero, P. Beardo-Villar, M. Soto-Delgado, R. Gavira-Moreno
Publikováno v:
Actas Urológicas Españolas. 38:339-345
Resumen Objetivo Describir los resultados obtenidos de la experiencia en el tratamiento con acetato de abiraterona (AA) en 25 hombres con cancer de prostata metastasico resistente a la castracion (CPMRC). Realizamos el analisis comparativo de la efic
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::3cb9944a202e52efd3fe400bd469a0e6
https://doi.org/10.1016/j.acuro.2013.11.004
https://doi.org/10.1016/j.acuro.2013.11.004